Skip to main content
    M

    MBX Biosciences, Inc. Common Stock (MBX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $53.12
    -2.82 (-5.04%)

    Market Cap: $2.78B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    MBX Biosciences, Inc. Common Stock (MBX) Earnings: Report Dates and Results

    Updated Nov 9, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    MBX Biosciences, Inc. Common Stock (MBX) is expected to report earnings on Mar 10, 2027. In the quarter ended Sep 30, 2026, MBX Biosciences, Inc. Common Stock reported EPS of -$1.29, below the -$0.80 estimate. It beat the EPS estimate in 6 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    67%(6/9)
    Avg Surprise
    +1.27%

    Upcoming Estimates

    Reports Mar 10, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.99
    Range-$1.35 - -$0.84
    12 analysts
    Revenue Consensus
    N/A
    RangeN/A
    9 analysts
    Reports May 5, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus-$0.99
    Range-$1.10 - -$0.89
    4 analysts
    EPS Revisions
    0
    2
    30d
    EPS Estimate DriftChange to current
    90d ago-$0.92-8.0%
    60d ago-$0.92-8.0%
    30d ago-$0.92-8.0%
    7d ago-$0.92-8.0%
    Current-$0.99
    Revenue Consensus
    N/A
    RangeN/A
    3 analysts

    Next Report

    MBX has an expected report date of Mar 10, 2027.

    Earnings History

    Of the 9 quarters below that had an estimate, MBX beat 6 and missed 3. The widest gap in the table came in the quarter ended Sep 30, 2026, when EPS landed 61.25% below the estimate.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReported
    Sep 30, 2026-$1.29-$0.80-$0.96 - -$0.74-61.25%MissN/A70 up, 4 downNov 9, 2026
    Jun 30, 2026-$0.78-$0.68-$0.78 - -$0.46-14.71%MissN/A76 up, 0 downAug 6, 2026
    Mar 31, 2026-$0.51-$0.58-$0.66 - -$0.54+12.07%BeatN/A70 up, 1 downMay 7, 2026
    Dec 31, 2025-$0.49-$0.60-$0.76 - -$0.46+17.88%BeatN/A71 up, 0 downMar 12, 2026
    Sep 30, 2025-$0.63-$0.68-$0.78 - -$0.51+7.35%BeatN/A52 up, 1 downNov 6, 2025
    Jun 30, 2025-$0.58-$0.77N/A+24.68%BeatN/AN/AN/AAug 7, 2025
    Mar 31, 2025-$0.71-$0.77N/A+7.79%BeatN/AN/AN/AMay 12, 2025
    Dec 31, 2024-$0.47-$0.59N/A+19.85%BeatN/AN/AN/AMar 17, 2025
    Sep 30, 2024-$2.78-$2.72N/A-2.21%MissN/AN/AN/ANov 7, 2024
    Jun 30, 2024-$11.47N/AN/AN/AN/AN/AN/AN/AAug 23, 2024
    Last 10 quarters

    Annual EPS

    Fiscal year endedEPSChange
    Sep 30, 2026-$2.58N/A
    Jun 30, 2026-$1.29N/A
    Dec 31, 2025-$2.41N/A
    Dec 31, 2024-$14.72N/A

    Frequently Asked Questions About MBX

    When is MBX Biosciences, Inc. Common Stock's next earnings date?

    MBX Biosciences, Inc. Common Stock's next earnings report is expected for Mar 10, 2027.

    Did MBX beat earnings estimates last quarter?

    No. MBX Biosciences, Inc. Common Stock reported EPS of -$1.29 for the quarter ended Sep 30, 2026, below the -$0.80 estimate by 61.25%.

    What EPS do analysts expect from MBX next quarter?

    The consensus EPS estimate for MBX Biosciences, Inc. Common Stock for the quarter ending Dec 31, 2026 is -$0.99 from 12 analysts, with estimates from -$1.35 to -$0.84.

    How often does MBX beat earnings estimates?

    MBX Biosciences, Inc. Common Stock beat the EPS estimate in 6 of the last 8 quarters, with an average surprise of +1.71%.